OCTAPHARMA USA, INC. et al v. BECERRA et al

Track this case

Case overview

Case Number:

1:22-cv-02782

Court:

District Of Columbia

Nature of Suit:

Other Statutory Actions

Judge:

Colleen Kollar-Kotelly

Firms

Companies

Sectors & Industries:

  1. February 08, 2024

    FDA Settles Allegations Of Uneven Blood Treatment Standards

    The U.S. Food and Drug Administration has settled a pharmaceutical company's lawsuit in D.C. federal court accusing the agency of subjecting the company's blood-clotting medication to costly clinical trials and higher standards than its competitors' products were required to meet.

  2. September 14, 2022

    Pharma Co. Challenges FDA's 'Uneven' Blood Drug Standards

    The maker of blood treatment Fibryga hit the U.S. Food and Drug Administration with a suit on Wednesday in D.C. federal court over what it says are the agency's "sharply uneven" standards for blood medications, arguing it was subjected to multimillion-dollar clinical trials while competitors were allowed to skip the "critical step."